Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122147735> ?p ?o ?g. }
- W2122147735 endingPage "1428" @default.
- W2122147735 startingPage "1417" @default.
- W2122147735 abstract "ABSTRACT A robust, economical process should leverage proven technology, yet be flexible enough to adopt emerging technologies which show significant benefit. Antibody and Fc‐fusion processes may capitalize on the high selectivity of an affinity capture step by reducing the total number of chromatographic steps to 2. Risk associated with this approach stems from the potentially increased time frame needed for process development as well as unforeseen changes in impurity profile during first scale‐up of drug substance (DS) for animal toxicology and clinical phase I trials (FIH) production, which could challenge a two‐step process to the point of failure. Two different purification strategies were pursued during process development for an FIH process of a dAB‐Fc fusion protein. A two‐step process was compared to a three‐step process. The two‐step process leveraged additives to maximize impurity reduction during affinity capture. While wash additives in combination with a mixed mode chromatography met all impurity reduction requirements, HCP levels were still higher as compared to the three‐step process. The three‐step process was implemented for manufacture of clinical material to mitigate risk. Biotechnol. Bioeng. 2015;112: 1417–1428. © 2015 Wiley Periodicals, Inc." @default.
- W2122147735 created "2016-06-24" @default.
- W2122147735 creator A5017096532 @default.
- W2122147735 creator A5029722629 @default.
- W2122147735 creator A5034892697 @default.
- W2122147735 creator A5039987229 @default.
- W2122147735 creator A5046748592 @default.
- W2122147735 creator A5055722790 @default.
- W2122147735 creator A5057782786 @default.
- W2122147735 creator A5064414376 @default.
- W2122147735 creator A5065963361 @default.
- W2122147735 creator A5074034944 @default.
- W2122147735 creator A5078077914 @default.
- W2122147735 date "2015-03-13" @default.
- W2122147735 modified "2023-10-16" @default.
- W2122147735 title "Development and scale-up of the recovery and purification of a domain antibody Fc fusion protein-comparison of a two and three-step approach" @default.
- W2122147735 cites W1927375915 @default.
- W2122147735 cites W1938323272 @default.
- W2122147735 cites W1967492739 @default.
- W2122147735 cites W1970962606 @default.
- W2122147735 cites W1976658649 @default.
- W2122147735 cites W1978177075 @default.
- W2122147735 cites W1983407946 @default.
- W2122147735 cites W1986427868 @default.
- W2122147735 cites W1987328338 @default.
- W2122147735 cites W1997014510 @default.
- W2122147735 cites W2004707896 @default.
- W2122147735 cites W2007469546 @default.
- W2122147735 cites W2008639298 @default.
- W2122147735 cites W2010948143 @default.
- W2122147735 cites W2017025903 @default.
- W2122147735 cites W2021900417 @default.
- W2122147735 cites W2025413405 @default.
- W2122147735 cites W2026720253 @default.
- W2122147735 cites W2038968935 @default.
- W2122147735 cites W2046231291 @default.
- W2122147735 cites W2046375794 @default.
- W2122147735 cites W2051430573 @default.
- W2122147735 cites W2052153910 @default.
- W2122147735 cites W2056433388 @default.
- W2122147735 cites W2059489323 @default.
- W2122147735 cites W2070373187 @default.
- W2122147735 cites W2071145815 @default.
- W2122147735 cites W2076708062 @default.
- W2122147735 cites W2076902391 @default.
- W2122147735 cites W2076971609 @default.
- W2122147735 cites W2083764534 @default.
- W2122147735 cites W2085593429 @default.
- W2122147735 cites W2088982336 @default.
- W2122147735 cites W2101436393 @default.
- W2122147735 cites W2101545092 @default.
- W2122147735 cites W2108934969 @default.
- W2122147735 cites W2116439954 @default.
- W2122147735 cites W2126756706 @default.
- W2122147735 cites W2135026274 @default.
- W2122147735 cites W2152461465 @default.
- W2122147735 cites W2161939869 @default.
- W2122147735 cites W34941183 @default.
- W2122147735 cites W4243947544 @default.
- W2122147735 cites W2094508121 @default.
- W2122147735 doi "https://doi.org/10.1002/bit.25561" @default.
- W2122147735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25683677" @default.
- W2122147735 hasPublicationYear "2015" @default.
- W2122147735 type Work @default.
- W2122147735 sameAs 2122147735 @default.
- W2122147735 citedByCount "14" @default.
- W2122147735 countsByYear W21221477352015 @default.
- W2122147735 countsByYear W21221477352016 @default.
- W2122147735 countsByYear W21221477352017 @default.
- W2122147735 countsByYear W21221477352018 @default.
- W2122147735 countsByYear W21221477352019 @default.
- W2122147735 countsByYear W21221477352021 @default.
- W2122147735 crossrefType "journal-article" @default.
- W2122147735 hasAuthorship W2122147735A5017096532 @default.
- W2122147735 hasAuthorship W2122147735A5029722629 @default.
- W2122147735 hasAuthorship W2122147735A5034892697 @default.
- W2122147735 hasAuthorship W2122147735A5039987229 @default.
- W2122147735 hasAuthorship W2122147735A5046748592 @default.
- W2122147735 hasAuthorship W2122147735A5055722790 @default.
- W2122147735 hasAuthorship W2122147735A5057782786 @default.
- W2122147735 hasAuthorship W2122147735A5064414376 @default.
- W2122147735 hasAuthorship W2122147735A5065963361 @default.
- W2122147735 hasAuthorship W2122147735A5074034944 @default.
- W2122147735 hasAuthorship W2122147735A5078077914 @default.
- W2122147735 hasConcept C104317684 @default.
- W2122147735 hasConcept C111919701 @default.
- W2122147735 hasConcept C123894998 @default.
- W2122147735 hasConcept C127413603 @default.
- W2122147735 hasConcept C138885662 @default.
- W2122147735 hasConcept C153083717 @default.
- W2122147735 hasConcept C154945302 @default.
- W2122147735 hasConcept C158525013 @default.
- W2122147735 hasConcept C171250308 @default.
- W2122147735 hasConcept C178790620 @default.
- W2122147735 hasConcept C179247698 @default.
- W2122147735 hasConcept C181199279 @default.
- W2122147735 hasConcept C183696295 @default.
- W2122147735 hasConcept C185592680 @default.